Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 19 March 2021 Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1981KB) Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 576KB)